Literature DB >> 15976374

Increased circulating endothelial progenitor cells are associated with survival in acute lung injury.

Ellen L Burnham1, W Robert Taylor, Arshed A Quyyumi, Mauricio Rojas, Kenneth L Brigham, Marc Moss.   

Abstract

RATIONALE: Repair of damaged endothelium is important in recovery from acute lung injury. In animal models, bone marrow-derived endothelial progenitor cells differentiate into mature endothelium and assist in repairing damaged vasculature.
OBJECTIVES: The quantity of endothelial progenitor cells in patients with acute lung injury is unknown. We hypothesize that increased numbers of circulating endothelial progenitor cells will be associated with an improved outcome in acute lung injury and the acute respiratory distress syndrome.
METHODS: Peripheral blood mononuclear cells from the buffy coat of patients with early acute lung injury (n=45), intubated control subjects (n=10), and healthy volunteers (n=7) were isolated using Ficoll density gradient centrifugation, and plated on fibronectin-coated cellware. After 24 hours, nonadherent cells were removed and replated on fibronectin-coated cellware at a concentration of 1x10(6) cells/well. Colony-forming units were counted after 7 days' incubation. MEASUREMENTS/MAIN
RESULTS: Endothelial progenitor cell colony numbers were significantly higher in patients with acute lung injury compared with healthy control subjects (p<0.05), but did not differ between patients with acute lung injury and intubated control subjects. However, in the 45 patients with acute lung injury, improved survival correlated with a higher colony count (p<0.04). Patients with acute lung injury with a colony count of >or= 35 had a mortality of 30%, compared with 61% in those with colony counts <35 (p<0.03), results that persisted in a multivariable analysis correcting for age, sex, and severity of illness.
CONCLUSIONS: An increased number of circulating endothelial progenitor cells in acute lung injury is associated with improved survival.

Entities:  

Mesh:

Year:  2005        PMID: 15976374     DOI: 10.1164/rccm.200410-1325OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  77 in total

Review 1.  Endothelial progenitor cells: current issues on characterization and challenging clinical applications.

Authors:  Thomas Resch; Andreas Pircher; Christian M Kähler; Johann Pratschke; Wolfgang Hilbe
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells.

Authors:  Sarah J Ohle; Asha Anandaiah; Attila J Fabian; Alan Fine; Darrell N Kotton
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-09       Impact factor: 6.914

3.  Translational research in ARDS patients: new biological phenotypes.

Authors:  Christian Patry; Stylianos E Orfanos; Neysan Rafat
Journal:  Intensive Care Med       Date:  2015-07-30       Impact factor: 17.440

Review 4.  Stem cells in sepsis and acute lung injury.

Authors:  Sushma K Cribbs; Greg S Martin
Journal:  Am J Med Sci       Date:  2011-04       Impact factor: 2.378

5.  Cell-based therapy for acute lung injury: are we there yet?

Authors:  Jae-Woo Lee; Yinggang Zhu; Michael A Matthay
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

Review 6.  [The role of endothelial progenitor cells in sepsis].

Authors:  G C Beck; N Rafat; B Yard; C Hanusch
Journal:  Anaesthesist       Date:  2007-05       Impact factor: 1.041

Review 7.  Recent advances in genetic predisposition to clinical acute lung injury.

Authors:  Li Gao; Kathleen C Barnes
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-02-13       Impact factor: 5.464

Review 8.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

Review 9.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.

Authors:  Bernard Thébaud; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2007-02-01       Impact factor: 21.405

10.  Biomarkers in acute lung injury: are we making progress?

Authors:  Sushma K Cribbs; Greg S Martin
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.